Navigation Links
Study finds taking probiotics has benefits for patients in hospitals
Date:6/4/2013

Patients in hospital who are on antibiotics may benefit from taking probiotics, according to researchers at St. Michaels Hospital.

Dr. Reena Pattani led a literature review that looked at the effectiveness of probiotics, live bacteria that can take up residence in digestive tracts, in treating common side effects of antibiotics, such as antibiotic-associated diarrhea and life-threatening side effects such as Clostridium difficile infection.

These two conditions are associated with high morbidity, mortality and health care costs, said Dr. Pattani, an internal medicine resident. Antibiotics are non-specific they target both our good and bad bacteria. And some of the good bacteria being killed off protect us from pathogens like C. difficle, a bacterium that can cause symptoms ranging from diarrhea to life-threatening inflammation of the body.

Previous studies have shown 10 per cent of patients who receive antibiotics while in hospital will get antibiotic-associated diarrhea and of these patients, 15 per cent of them will have diarrhea because of C. difficle.

Dr. Pattani and colleagues scanned available literature for studies that compared patients who received probiotics and antibiotics at the same time in hospital, with patients who received antibiotics alone to see if rates of antibiotic-associated diarrhea and C. difficle infection were lower in those who also received probiotics.

They pooled the results of 16 studies, looking at data from 3,403 patients, and found a significant reduction in both antibiotic-associated diarrhea and C. difficle infection in patients who took probiotics with their antibiotics.

The results are likely due to the powerful effects of probiotics, including their ability to populate the digestive tract with healthy bacteria and strengthen the immune system, Dr. Pattani said.

Hospitalization is a key risk factor for acquiring C. difficle infection, Dr. Pattani said. Probiotics can help improve the health of individual patients by preventing C. difficle while also reducing the transmission of C. difficle to other, non-infected people in the high-risk inpatient environment. We hope these results will prompt physicians to consider its use.

Dr. Pattani said that while the results of her study are encouraging, a larger study including more patients, and one that looks at what kind of probiotics work best and at what doses needs to be done before hospital-wide policies can be made.

The paper appeared online in the journal Open Medicine today.

Dr. Pattani is a resident at the University of Toronto and St. Michaels incoming chief resident.


'/>"/>

Contact: Leslie Shepherd
shepherdl@smh.ca
416-864-6094
St. Michael's Hospital
Source:Eurekalert

Related biology news :

1. New study explains cognitive ability differences among the elderly
2. Oncologists are stressed and have difficulty discussing death with patients -- Ben-Gurion U. study
3. Stem cell study could aid quest to combat range of diseases
4. New study predicts rising irrigation costs, reduced yields for US corn
5. Circadian rhythms control bodys response to intestinal infections, UCI-led study finds
6. Study: Pedometer program helps motivate participants to sit less, move more
7. Thermal limit for animal life redefined by first lab study of deep-sea vent worms
8. Recovery of Hawaiian green sea turtles still short of historic levels, Stanford-led study suggests
9. Nordic diet lowers cholesterol, study finds
10. Study explores 100 year increase in forestry diseases
11. Reforestation study shows trade-offs between water, carbon and timber
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/3/2017)...  Data captured by IsoCode, IsoPlexis Corporation,s ... statistically significant association between the potency of ... objective response of cancer patients post-treatment. The ... cancer patients will respond to CAR-T cell ... to improve both pre-infusion potency testing and cell ...
(Date:3/29/2017)... 29, 2017  higi, the health IT company that ... North America , today announced a Series B ... of EveryMove. The new investment and acquisition accelerates higi,s ... to transform population health activities through the collection and ... higi collects and secures data today on behalf ...
(Date:3/24/2017)... 2017 Research and Markets has announced the ... & Trends - Industry Forecast to 2025" report to their ... The Global ... CAGR of around 15.1% over the next decade to reach approximately ... the market estimates and forecasts for all the given segments on ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... ... 2017 , ... BioMedGPS announces expanded coverage of SmartTRAK Business ... US Hemostats & Sealants. , SmartTRAK’s US Market for Hemostats and Sealants module ... and biologic sealants used in surgical applications. BioMedGPS estimates the market will grow ...
(Date:10/11/2017)... , ... October 11, 2017 , ... ... gene in its endogenous context, enabling overexpression experiments and avoiding the use of ... small RNA guides is transformative for performing systematic gain-of-function studies. , This ...
(Date:10/11/2017)... 11, 2017  VMS BioMarketing, a leading provider of patient ... Clinical Nurse Educator (CNE) network, which will launch this week. ... among health care professionals to enhance the patient care experience ... and other health care professionals to help women who have ... ...
(Date:10/11/2017)... ... October 11, 2017 , ... ... granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal Transducer and Activator ... osteosarcoma. SBT-100 is able to cross the cell membrane and bind intracellular STAT3 ...
Breaking Biology Technology: